Previous close | 38.72 |
Open | 38.72 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 38.72 - 38.72 |
52-week range | 26.55 - 66.96 |
Volume | |
Avg. volume | 1,937 |
Market cap | 12.11B |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | 15.61 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.18 (3.05%) |
Ex-dividend date | 17 May 2023 |
1y target est | N/A |
Fresenius Medical Care AG & Co. KGaA / Key word(s): Strategic Company DecisionFresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation21-Feb-2023 / 19:05 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Bad Homburg, 21 February 2023. The Supervisory Board of Fre
Fresenius Medical Care AG & Co. KGaA / Key word(s): MiscellaneousFresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation09-Feb-2023 / 16:26 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Bad Homburg, February 9, 2023Following pre
EQS-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): PersonnelFresenius Medical Care AG & Co. KGaA: Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care 05.12.2022 / 23:39 CET/CESTThe issuer is solely responsible for the content of this announcement.Helen Giza (54) has been appointed Chief Executive Officer of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, with immediate effect. Previously, she w